GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | £32.7BFY2025 | +6.0% |
| Gross profit | £23.7BFY2025 | +7.6% |
| Operating income | £7.9BFY2025 | +5.8% |
| Net income | £5.7BFY2025 | −0.1% |
| EPS | £1.39FY2025 | −0.5% |
| Free cash flow | £6.4BFY2025 | −3.0% |